Background: Ultrasound is the most commonly used imaging modality for assessing carotid artery stenosis. A number of studies have demonstrated that surface irregularities, heterogeneous echotexture and hypoechoic plaques are risk factors for acute ischemic stroke. We performed a systematic review and meta-analysis of the literature to better define the risk of stroke based on the sonographic characteristics of carotid plaques. Materials and Methods: We performed a comprehensive search for studies reporting imaging findings of symptomatic and asymptomatic carotid plaques on ultrasound using MEDLINE and EMBASE. We included both case-control and cohort studies examining the relationship between complex plaque and acute ischemic stroke or transient ischemic attack. Complex plaque was defined as plaque that had any of the following characteristics: heterogeneous echogenicity, echolucency, neovascularization, surface irregularity, ulceration, and intraplaque motion. Meta-analyses using the random-effects model were performed for complex plaque and each of the individual complex plaque characteristics. p < 0.05 was considered statistically significant. We explored the impact of publication bias by constructing funnel plots and testing their symmetry. We conducted the meta-analysis using Comprehensive Meta-analysis version 2.2, Englewood, N.J., USA. Results: A total of 1,013 articles were screened and 23 studies with 6,706 carotid plaques were included. Ultrasound plaque characteristics with a higher prevalence in individuals with symptomatic compared to asymptomatic carotid artery stenosis included plaque neovascularity (OR = 19.68, 95% CI = 3.14-123.16), complex plaque (OR = 5.12, 95% CI = 3.42-7.67), plaque ulceration (OR = 3.58, 95% CI = 1.66-7.71), plaque echolucency (OR = 3.99, 95% CI = 3.06-5.19) and intraplaque motion (OR = 1.57, 95% CI = 1.02-2.41). Variables not associated with symptom status included heterogenous echotexture (OR = 2.68, 95% CI = 0.56-12.80) and surface irregularity without ulceration (OR = 2.38, 95% CI = 0.70-8.11). No evidence of publication bias was observed based on Eggers test (p value of 0.05 for complex plaque and 0.53 for plaque echolucency). The remaining plaque features had insufficient data to assess for publication bias. Conclusions: Our meta-analysis and systematic review of the literature demonstrated that plaques with complex features, particularly those with echolucency, neovascularization, ulceration and intraplaque motion are associated with ischemic symptoms. Assessment of carotid plaque on ultrasound may provide stroke risk information beyond measurement of luminal stenosis. Thus, sonographic evaluation of carotid artery stenosis should focus on the detection of these plaque characteristics in addition to quantifying the degree of stenosis.

1.
Fairhead JF, Rothwell PM: The need for urgency in identification and treatment of symptomatic carotid stenosis is already established. Cerebrovasc Dis 2005;19:355-358.
2.
North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
3.
Endarterectomy for asymptomatic carotid artery stenosis. Executive committee for the asymptomatic carotid atherosclerosis study. JAMA 1995;273:1421-1428.
4.
European Carotid Surgery Trialists' Collaborative Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European carotid surgery trial (ECST). Lancet 1998;351:1379-1387.
5.
Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 1998;339:1415-1425.
6.
Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D; MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-1502.
7.
Hobson RW 2nd, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, Wright CB: Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The veterans affairs cooperative study group. N Engl J Med 1993;328:221-227.
8.
Freilinger TM, Schindler A, Schmidt C, Grimm J, Cyran C, Schwarz F, Bamberg F, Linn J, Reiser M, Yuan C, Nikolaou K, Dichgans M, Saam T: Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging 2012;5:397-405.
9.
Horie N, Morikawa M, Ishizaka S, Takeshita T, So G, Hayashi K, Suyama K, Nagata I: Assessment of carotid plaque stability based on the dynamic enhancement pattern in plaque components with multidetector CT angiography. Stroke 2012;43:393-398.
10.
Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG; International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group: Evaluating non-randomised intervention studies. Health Technol Assess 2003;7:iii-x, 1-173.
11.
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
12.
Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
13.
Aldemir E, Apaydin M, Varer M, Uluc E: Echolucency of carotid plaques and cerebrovascular events. J Clin Ultrasound 2012;40:399-404.
14.
Mathiesen EB, Bønaa KH, Joakimsen O: Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromso study. Circulation 2001;103:2171-2175.
15.
Singh AS, Atam V, Jain N, Yathish BE, Patil MR, Das L: Association of carotid plaque echogenicity with recurrence of ischemic stroke. N Am J Med Sci 2013;5:371-376.
16.
Gupta A, Kesavabhotla K, Baradaran H, Kamel H, Pandya A, Giambrone AE, Wright D, Pain KJ, Mtui EE, Suri JS, Sanelli PC, Mushlin AI: Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis. Stroke 2015;46:91-97.
17.
Golledge J, Cuming R, Ellis M, Davies AH, Greenhalgh RM: Carotid plaque characteristics and presenting symptom. Br J Surg 1997;84:1697-1701.
18.
Madani A, Beletsky V, Tamayo A, Munoz C, Spence JD: High-risk asymptomatic carotid stenosis: ulceration on 3D ultrasound vs TCD microemboli. Neurology 2011;77:744-750.
19.
Pedro LM, Pedro MM, Gonçalves I, Carneiro TF, Balsinha C, Fernandes e Fernandes R, Fernandes e Fernandes J: Computer-assisted carotid plaque analysis: characteristics of plaques associated with cerebrovascular symptoms and cerebral infarction. Eur J Vasc Endovasc Surg 2000;19:118-123.
20.
Ajduk M, Pavić L, Bulimbasić S, Sarlija M, Pavić P, Patrlj L, Brkljacić B: Multidetector-row computed tomography in evaluation of atherosclerotic carotid plaques complicated with intraplaque hemorrhage. Ann Vasc Surg 2009;23:186-193.
21.
Das M, Braunschweig T, Mühlenbruch G, Mahnken AH, Krings T, Langer S, Koeppel T, Jacobs M, Günther RW, Mommertz G: Carotid plaque analysis: comparison of dual-source computed tomography (CT) findings and histopathological correlation. Eur J Vasc Endovasc Surg 2009;38:14-19.
22.
Eliasziw M, Streifler JY, Fox AJ, Hachinski VC, Ferguson GG, Barnett HJ: Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. North American symptomatic carotid endarterectomy trial. Stroke 1994;25:304-308.
23.
Watanabe Y, Nagayama M: MR plaque imaging of the carotid artery. Neuroradiology 2010;52:253-274.
24.
Watanabe Y, Nagayama M, Suga T, Yoshida K, Yamagata S, Okumura A, Amoh Y, Nakashita S, Van Cauteren M, Dodo Y: Characterization of atherosclerotic plaque of carotid arteries with histopathological correlation: vascular wall MR imaging vs. color Doppler ultrasonography (US). J Magn Reson Imaging 2008;28:478-485.
25.
Saba L, Caddeo G, Sanfilippo R, Montisci R, Mallarini G: CT and ultrasound in the study of ulcerated carotid plaque compared with surgical results: potentialities and advantages of multidetector row CT angiography. AJNR Am J Neuroradiol 2007;28:1061-1066.
26.
Ballotta E, Angelini A, Mazzalai F, Piatto G, Toniato A, Baracchini C: Carotid endarterectomy for symptomatic low-grade carotid stenosis. J Vasc Surg 2014;59:25-31.
27.
Muraki M, Mikami T, Yoshimoto T, Fujimoto S, Tokuda K, Kaneko S, Kashiwaba T: New criteria for the sonographic diagnosis of a plaque ulcer in the extracranial carotid artery. AJR Am J Roentgenol 2012;198:1161-1166.
28.
Wang YH, Zheng QC, Yuan GX, Ren JH: The application of ultrasound B-flow imaging in detection of carotid atherosclerotic micro-vessel with ischemic cerebrovascular disease. Saudi Med J 2012;33:1080-1086.
29.
Coli S, Magnoni M, Sangiorgi G, Marrocco-Trischitta MM, Melisurgo G, Mauriello A, Spagnoli L, Chiesa R, Cianflone D, Maseri A: Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol 2008;52:223-230.
30.
Vavuranakis M, Sigala F, Vrachatis DA, Papaioannou TG, Filis K, Kavantzas N, Kalogeras KI, Massoura C, Toufektzian L, Kariori MG, Vlasseros I, Kallikazaros I, Stefanadis C: Quantitative analysis of carotid plaque vasa vasorum by CEUS and correlation with histology after endarterectomy. Vasa 2013;42:184-195.
31.
Staub D, Patel MB, Tibrewala A, Ludden D, Johnson M, Espinosa P, Coll B, Jaeger KA, Feinstein SB: Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke 2010;41:41-47.
32.
Xiong L, Deng YB, Zhu Y, Liu YN, Bi XJ: Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology 2009;251:583-589.
33.
Zhu Y, Deng YB, Liu YN, Bi XJ, Sun J, Tang QY, Deng Q: Use of carotid plaque neovascularization at contrast-enhanced US to predict coronary events in patients with coronary artery disease. Radiology 2013;268:54-60.
34.
Clevert DA, Sommer WH, Helck A, Saam T, Reiser M: Improved carotid atherosclerotic plaques imaging with contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc 2011;48:141-148.
35.
Huang PT, Huang FG, Zou CP, Sun HY, Tian XQ, Yang Y, Tang JF, Yang PL, Wang XT: Contrast-enhanced sonographic characteristics of neovascularization in carotid atherosclerotic plaques. J Clin Ultrasound 2008;36:346-351.
36.
Vicenzini E, Giannoni MF, Puccinelli F, Ricciardi MC, Altieri M, Di Piero V, Gossetti B, Valentini FB, Lenzi GL: Detection of carotid adventitial vasa vasorum and plaque vascularization with ultrasound cadence contrast pulse sequencing technique and echo-contrast agent. Stroke 2007;38:2841-2843.
37.
Iannuzzi A, Wilcosky T, Mercuri M, Rubba P, Bryan FA, Bond MG: Ultrasonographic correlates of carotid atherosclerosis in transient ischemic attack and stroke. Stroke 1995;26:614-619.
38.
Kume S, Hama S, Yamane K, Wada S, Nishida T, Kurisu K: Vulnerable carotid arterial plaque causing repeated ischemic stroke can be detected with B-mode ultrasonography as a mobile component: Jellyfish sign. Neurosurg Rev 2010;33:419-430.
39.
Meairs S, Hennerici M: Four-dimensional ultrasonographic characterization of plaque surface motion in patients with symptomatic and asymptomatic carotid artery stenosis. Stroke 1999;30:1807-1813.
40.
Lenzi GL, Vicenzini E: The ruler is dead: an analysis of carotid plaque motion. Cerebrovasc Dis 2007;23:121-125.
41.
Hennerici MG: The unstable plaque. Cerebrovasc Dis 2004;17(suppl 3):17-22.
42.
Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-1375.
43.
Steinberg D, Witztum JL: Lipoproteins and atherogenesis. Current concepts. JAMA 1990;264:3047-3052.
44.
Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ: Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984;310:175-177.
45.
Falk E: Why do plaques rupture? Circulation 1992;86(6 suppl):III30-III42.
46.
Mughal MM, Khan MK, DeMarco JK, Majid A, Shamoun F, Abela GS: Symptomatic and asymptomatic carotid artery plaque. Expert Rev Cardiovasc Ther 2011;9:1315-1330.
47.
AbuRahma AF, Wulu JT Jr, Crotty B: Carotid plaque ultrasonic heterogeneity and severity of stenosis. Stroke 2002;33:1772-1775.
48.
Brajović MD, Marković N, Loncar G, Sekularac N, Kordić D, Despotović N, Erceg P, Donfrid B, Stefanović Z, Bajcetić M, Brajović L, Savić Z: The influence of various morphologic and hemodynamic carotid plaque characteristics on neurological events onset and deaths. ScientificWorldJournal 2009;9:509-521.
49.
Elatrozy T, Nicolaides A, Tegos T, Griffin M: The objective characterisation of ultrasonic carotid plaque features. Eur J Vasc Endovasc Surg 1998;16:223-230.
50.
el-Barghouty N, Nicolaides A, Bahal V, Geroulakos G, Androulakis A: The identification of the high risk carotid plaque. Eur J Vasc Endovasc Surg 1996;11:470-478.
51.
Giannoni MF, Vicenzini E, Citone M, Ricciardi MC, Irace L, Laurito A, Scucchi LF, Di Piero V, Gossetti B, Mauriello A, Spagnoli LG, Lenzi GL, Valentini FB: Contrast carotid ultrasound for the detection of unstable plaques with neoangiogenesis: a pilot study. Eur J Vasc Endovasc Surg 2009;37:722-727.
52.
Giannoukas AD, Sfyroeras GS, Griffin M, Saleptsis V, Antoniou GA, Nicolaides AN: Association of plaque echostructure and cardiovascular risk factors with symptomatic carotid artery disease. Vasa 2009;38:357-364.
53.
Carra G, Visonà A, Bonanome A, Lusiani L, Pesavento R, Bortolon M, Pagnan A: Carotid plaque morphology and cerebrovascular events. Int Angiol 2003;22:284-289.
54.
Kakkos SK, Nicolaides AN, Kyriacou E, Daskalopoulou SS, Sabetai MM, Pattichis CS, Geroulakos G, Griffin MB, Thomas D: Computerized texture analysis of carotid plaque ultrasonic images can identify unstable plaques associated with ipsilateral neurological symptoms. Angiology 2011;62:317-328.
55.
Kalogeropoulos A, Terzis G, Chrysanthopoulou A, Hahalis G, Siablis D, Alexopoulos D: Risk for transient ischemic attacks is mainly determined by intima-media thickness and carotid plaque echogenicity. Atherosclerosis 2007;192:190-196.
56.
Kardoulas DG, Katsamouris AN, Gallis PT, Philippides TP, Anagnostakos NK, Gorgoyannis DS, Gourtsoyannis NC: Ultrasonographic and histologic characteristics of symptom-free and symptomatic carotid plaque. Cardiovasc Surg 1996;4:580-590.
57.
Kobayashi E, Ono J, Hirai S, Yamakami I, Saeki N, Yamaura A: Detection of unstable plaques in patients with carotid stenosis using B-mode ultrasonography. Interv Neuroradiol 2000;6:165-170.
58.
Ruiz-Ares G, Fuentes B, Martínez-Sánchez P, Martínez-Martínez M, Díez-Tejedor E: Utility of the assessment of echogenicity in the identification of symptomatic carotid artery atheroma plaques in ischemic stroke patients. Cerebrovasc Dis 2011;32:535-541.
59.
Sarzyńska-Długosz I, Nowaczenko M, Błazejewska-Hyzorek B, Rozenfeld A, Gromadzka G, Członkowska A: Echolucent internal carotid artery plaques are a risk factor for stroke. Neurol Neurochir Pol 2008;42:91-98.
60.
Steffen CM, Gray-Weale AC, Byrne KE, Lusby RJ: Carotid artery atheroma: ultrasound appearance in symptomatic and asymptomatic vessels. Aust N Z J Surg 1989;59:529-534.
61.
Varetto G, Gibello L, Bergamasco L, Sapino A, Castellano I, Garneri P, Rispoli P: Contrast enhanced ultrasound in atherosclerotic carotid artery disease. Int Angiol 2012;31:565-571.
62.
el-Barghouti N, Nicolaides AN, Tegos T, Geroulakos G: The relative effect of carotid plaque heterogeneity and echogenicity on ipsilateral cerebral infarction and symptoms of cerebrovascular disease. Int Angiol 1996;15:300-306.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.